FR2160995A1 - - Google Patents

Info

Publication number
FR2160995A1
FR2160995A1 FR7241624A FR7241624A FR2160995A1 FR 2160995 A1 FR2160995 A1 FR 2160995A1 FR 7241624 A FR7241624 A FR 7241624A FR 7241624 A FR7241624 A FR 7241624A FR 2160995 A1 FR2160995 A1 FR 2160995A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7241624A
Other versions
FR2160995B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of FR2160995A1 publication Critical patent/FR2160995A1/fr
Application granted granted Critical
Publication of FR2160995B1 publication Critical patent/FR2160995B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C07D235/32—Benzimidazole-2-carbamic acids, unsubstituted or substituted; Esters thereof; Thio-analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7241624A 1971-11-24 1972-11-23 Expired FR2160995B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB5449871A GB1410017A (en) 1971-11-24 1971-11-24 Benzimidazole derivatives
US30871972A 1972-11-22 1972-11-22
US05/511,227 US3935314A (en) 1971-11-24 1974-10-02 Anti-hypertensive compositions of benzimidazole derivatives

Publications (2)

Publication Number Publication Date
FR2160995A1 true FR2160995A1 (fr) 1973-07-06
FR2160995B1 FR2160995B1 (fr) 1975-10-17

Family

ID=27260358

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7241623A Expired FR2160994B1 (fr) 1971-11-24 1972-11-23
FR7241624A Expired FR2160995B1 (fr) 1971-11-24 1972-11-23

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR7241623A Expired FR2160994B1 (fr) 1971-11-24 1972-11-23

Country Status (9)

Country Link
US (1) US3935314A (fr)
JP (3) JPS4862762A (fr)
AT (1) AT319938B (fr)
AU (1) AU4916772A (fr)
BE (2) BE791907A (fr)
DE (2) DE2257311A1 (fr)
FR (2) FR2160994B1 (fr)
GB (1) GB1410017A (fr)
NL (2) NL7215919A (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH632268A5 (de) 1977-01-14 1982-09-30 Sandoz Ag Verfahren zur herstellung von neuen heterocyclylaminoderivaten.
DE2816627A1 (de) * 1978-04-17 1979-10-25 Beiersdorf Ag 2-(n-amino-isoindolinyl)-imidazolin und verfahren zu seiner herstellung
DE2905501A1 (de) * 1979-02-14 1980-08-28 Beiersdorf Ag Neue kondensierte, stickstoffhaltige heterocyclische verbindungen und verfahren zu deren herstellung
US5478858A (en) * 1993-12-17 1995-12-26 The Procter & Gamble Company 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists
EP0775134A4 (fr) * 1994-08-04 1997-08-13 Synaptic Pharma Corp Nouveaux derives de benzimidazole
US6495583B1 (en) 1997-03-25 2002-12-17 Synaptic Pharmaceutical Corporation Benzimidazole derivatives
RU2012120784A (ru) * 2009-11-12 2013-12-20 Селвита С.А. Соединение, способ его получения, фармацевтическая композиция, применение соединения, способ модулирования или регулирования сериновых/треониновых киназ и средство, модулирующее сериновые/треониновые киназы
US8604217B2 (en) * 2009-11-12 2013-12-10 Selvita S.A. Compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
US20150203812A1 (en) * 2014-01-20 2015-07-23 Francesco Tombola Inhibitors of Voltage Gated Ion Channels
TWI685338B (zh) * 2017-12-14 2020-02-21 柯瑞 伊里阿斯 Ｊ 使用非可吸收性口服投予之化合物之包括第2型糖尿病、脂肪肝炎及相關病況之人類代謝症候群之預防及治療

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3749789A (en) * 1970-02-27 1973-07-31 Merck & Co Inc Anthelmintic compositions containing benzimidazoles and method of use
FR2116246B1 (fr) * 1970-12-01 1974-03-22 Delalande Sa
US3749734A (en) * 1971-07-12 1973-07-31 Merck & Co Inc 1-cyanobenzimidazoles
US3738994A (en) * 1971-08-13 1973-06-12 Merck & Co Inc 2-cyano-polyhalobenzimidazoles
US3760081A (en) * 1972-01-24 1973-09-18 Upjohn Co Method of treatment

Also Published As

Publication number Publication date
GB1410017A (en) 1975-10-15
BE791908A (fr) 1973-05-24
US3935314A (en) 1976-01-27
AU4916772A (en) 1974-05-23
JPS4862764A (fr) 1973-09-01
AT319938B (de) 1975-01-10
FR2160994B1 (fr) 1976-05-21
JPS4862762A (fr) 1973-09-01
FR2160995B1 (fr) 1975-10-17
FR2160994A1 (fr) 1973-07-06
NL7215920A (fr) 1973-05-28
BE791907A (fr) 1973-05-24
JPS4862763A (fr) 1973-09-01
DE2257312A1 (de) 1973-06-07
NL7215919A (fr) 1973-05-28
DE2257311A1 (de) 1973-06-07

Similar Documents

Publication Publication Date Title
ATA136472A (fr)
AR196074A1 (fr)
AU2658571A (fr)
AU2691671A (fr)
AU2485671A (fr)
AU3005371A (fr)
AU2894671A (fr)
AU2742671A (fr)
AU2941471A (fr)
AU2952271A (fr)
AU2684071A (fr)
AU2564071A (fr)
AU2684171A (fr)
AU2836771A (fr)
AU3038671A (fr)
AU2503871A (fr)
AU3025871A (fr)
AU2577671A (fr)
AU2588771A (fr)
AU2654071A (fr)
AU2473671A (fr)
AU2669471A (fr)
AU2456871A (fr)
AU2940971A (fr)
AU2455871A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse